Obese people 'no longer at higher risk of heart attack' after huge treatment boost

A recent health advisory has warned individuals taking specific types of statins—namely simvastatin, pravastatin, and fluvastatin—that taking them at the wrong time of day might diminish their effectiveness. This guidance comes from experts emphasizing the importance of adhering to prescribed schedules for optimal results. Statins are a class of drugs primarily used to lower cholesterol levels in the bloodstream, thereby reducing the risk of heart attacks and strokes.

These particular statins are categorized as shorter-acting, meaning they remain active in the body for a relatively brief period. As a result, they are typically recommended to be taken in the evening or before bedtime. This timing aligns with the natural rhythm of cholesterol production in the human body, which peaks during the night, particularly between midnight and 3 a.m. By taking these medications at night, the drug remains in the system when the liver is most actively producing cholesterol, thus maximizing its efficacy.

The National Health Service (NHS) in the United Kingdom supports this recommendation, noting that simvastatin, for instance, should ideally be taken late in the evening and at approximately the same time each day. This consistency helps ensure the medication works optimally when the body produces the majority of its cholesterol. The NHS also emphasizes that most individuals prescribed statins will require long-term use to maintain the benefits of reduced cholesterol levels and lowered cardiovascular risk.

Cambridge University Hospitals NHS Foundation Trust further underscores the importance of following dosage instructions carefully. It states that statins are generally taken at night, and healthcare professionals may adjust dosages based on subsequent cholesterol test results. Patients are strongly advised against altering their medication schedule without consulting a healthcare provider. This caution stems from the understanding that deviating from the prescribed regimen could lead to suboptimal treatment outcomes.

Not all statins adhere to the same guidelines. For example, longer-acting statins such as atorvastatin can be taken at any time of day, as long as the timing is consistent. The British Heart Foundation echoes this point, advising individuals to take their medication exactly as prescribed to manage cholesterol levels effectively and reduce the risk of cardiovascular disease. Those uncertain about the correct timing for their specific statin are encouraged to seek guidance from their general practitioner or pharmacist rather than self-adjusting their medication schedule.

In parallel developments, a significant study published in *The Lancet* has revealed that obese individuals over the age of 40 now exhibit similar cholesterol and blood pressure levels to those of healthy weight, largely due to the widespread use of medications such as statins. This study analyzed data from nearly one million adults across several countries, including England, Japan, South Korea, Taiwan, Thailand, Finland, and the United States. Researchers observed that differences in unhealthy cholesterol levels and blood pressure between older adults with obesity and those with a normal BMI have either narrowed or completely disappeared in developed nations.

Professor Majid Ezzati, one of the study’s authors from Imperial College London, noted that the use of medications to lower blood pressure and cholesterol has significantly reduced cardiovascular risk among middle-aged and older adults with obesity, bringing their levels close to those of individuals with a normal BMI. He emphasized the importance of this finding, particularly given the growing trend of prescribing weight-loss medications. The study aims to provide insight into the cardiovascular health of individuals likely to receive such prescriptions, enabling healthcare systems to better understand the combined benefits of weight-loss medications and existing treatments for blood pressure and cholesterol management.

Despite these encouraging results, experts caution that obesity still poses broader health risks beyond cardiovascular concerns. Professor Bryan Williams from the British Heart Foundation highlighted that while the study showcases the effectiveness of current treatments, it is crucial not to overlook the comprehensive negative impacts of obesity, which include an increased risk of diabetes, kidney disease, and certain cancers. He urged continued efforts toward preventing and reducing obesity to achieve a wide array of health benefits, potentially eliminating the need for additional medications.

The study also found that for adults under the age of 40, those with obesity still exhibited higher levels of unhealthy cholesterol and elevated blood pressure compared to their healthier-weight counterparts. This disparity underscores the necessity of early intervention, including lifestyle changes, regular screenings, and appropriate medication, to mitigate long-term cardiovascular complications associated with obesity.

As the landscape of cardiovascular care evolves, ongoing research and clinical practice will continue to refine treatment approaches, ensuring that individuals receive the most effective and personalized care possible. Healthcare providers and patients alike must remain vigilant in adhering to prescribed regimens and staying informed about emerging evidence in the field of cardiovascular health.